20th Annual DIA EuroMeeting includes 11 Themes, 350 Speakers and Europe´s Largest Exhibit Hall

The Drug Information Association (DIA) will celebrate the 20th
Anniversary of the EuroMeeting in Barcelona, Spain, from March 3-5,
2008.

The EuroMeeting will feature presentations by more than 350
speakers, 20 pre-conference tutorials, student and professional poster
sessions, over 250 exhibitors and exciting networking events. This
year´s event is divided into 11 themes, rather than the traditional
tracks, with up to nine sessions in each theme. This will allow
attendees to embrace the entire multidisciplinary concept of the
meeting.

HOT TOPICS

-- Advanced Therapies in the EU - Today and Tomorrow

-- Communication on Risk and Safety Issues of Medicines

-- First in Man Trials - Impact of New Guidelines

-- National and/or CHMP Advice: A Place for Each?

-- Surrogate Endpoints: Balancing the Objectives of Patients,
Industry and Regulators

-- Use of Electronic Health Records in Clinical Research

-- Eudra Databases

-- Pharmacogenomics--Present and Future Directions

The European Regulatory Forum will provide an update on the work
of the CHMP and Scientific Advisory Groups (SAGs), the Co-ordination
group CMD(h), the work of the Paediatric Committee and the assessment
of paediatric data, new pharmacovigilance activities, Quality and
Safety Working parties and the hot topics in telematics.

Spanish Satellite Meeting

The Spanish Agency of Medicines and Medical Devices will examine
the activities and aims of the Spanish Agency and the challenges for
the coming years.

Japanese Session

The Pharmaceuticals and Medical Devices Agency (PMDA) will explain
the current PMDA/Japanese drug regulatory environment and present PMDA
perspectives for successful global drug development including Japan.

About the Drug Information Association (DIA)

The Drug Information Association (DIA) serves more than 30,000
professionals in the biotechnology, pharmaceutical and regulatory
industries worldwide. Through its domestic and international meetings,
training courses, workshops and webinars, DIA provides a neutral
global forum for the exchange of information critical to the
advancement of the drug discovery and lifecycle management processes.
Headquartered in Horsham, PA, USA, and with offices in Basel,
Switzerland and Tokyo, Japan, the Association is led by its
volunteer-based board of directors and executive management team. For
more information, visit www.diahome.org or call 215-442-6100.